Frequently Asked Questions on Non-Surgical Devices for Voluntary Medical Male Circumcision for HIV Prevention

Basic information on non-surgical devices with a focus on the implications of WHO prequalification and next steps for product introduction. 

An Action Agenda to End AIDS: Where are we in realizing the promise of beginning to end AIDS?

Issued in 2013, a year after An Action Agenda to End AIDS was first published, this document gives a status report on key actions and provides priority recommendations. 

A Cascade of Hope and Questions: Anticipating results of ARV-based HIV prevention trials

A report designed to help advocates understand results of the 2010 CAPRISA 004 trial and how they related to the research agenda for ARV-based prevention strategies.

A Call to Action on Voluntary Medical Male Circumcision: Implementing a key component of combination HIV prevention

A comprehensive 2012 report from civil society about the state of voluntary medical male circumcision in Africa. Includes priority recommendations and in-depth discussion of factors influencing national scale-up efforts.  

A Call to Action on Voluntary Medical Male Circumcision: Executive Summary

This is the executive summary of a 2012 joint civil society report on voluntary medical male circumcision. The document focuses on priority recommendations for action. 

Understanding the Results of CAPRISA 004

A 2010 document discussing the results of the CAPRISA 004 microbicide gel trial. It explores the implications of the data and outlines the next steps in evaluating tenofovir gel.

PrEP: A new option for women for safer loving

A brochure designed for women who want information on whether PrEP is the right prevention option for them. 

Influencing PEPFAR COPs: An Advocate’s Guide

A two-page resource designed for advocates working in the US and in countries receiving PEPFAR funding. It contains background information and an infographic on how PEPFAR Country Operating Plans are developed and how advocates can influence them. 

From Research to Reality: Investing in HIV prevention research in a challenging landscape

Summary of findings from report on 2012 investment and funding trends in HIV prevention research and development (R&D).

Adherence in HIV Prevention Research: A primer for HIV prevention advocates

A two-page resource providing simple explanations of how adherence is defined and measured in biomedical HIV prevention trials, with a focus on PrEP and microbicides.